Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections

NANot yet recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Rare Genetic DiseaseAcute Necrotizing Encephalopathy
Interventions
OTHER

Blood sampling for inflammatory phenotype analysis

Blood sampling for basal and post-stimulation inflammatory phenotype analysis

GENETIC

Blood sampling for genetic analysis

Collection of a blood tube for whole exome sequencing of the RANBP2 gene and analysis of the presence of the mutation by RTqPCR.

Trial Locations (1)

34295

CHU Gui de Chauliac, Montpellier

All Listed Sponsors
collaborator

Institut de Recherche en Infectiologie de Montpellier (CNRS)

UNKNOWN

collaborator

A*STAR Infectious Diseases Labs

INDUSTRY

lead

University Hospital, Montpellier

OTHER

NCT06731790 - Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections | Biotech Hunter | Biotech Hunter